PROMIS Fatigue Score

Accurate fatigue scores are described as essential for assessing benralizumab's impact on patient-reported outcomes. The corrections improve accurate reporting of patient-reported fatigue burden in the benralizumab trial. Accurate fatigue scores are important for reporting patient-reported fatigue burden. Accurate PROMIS fatigue scores are essential for evaluating the effect of treatment on patient-reported outcomes. Accurate PROMIS Fatigue scores are essential for assessing patient-reported outcomes in the benralizumab trial. The corrections improve reporting of patient-reported fatigue burden in the trial. The correction to the PROMIS Fatigue score represents a 4-point upward shift in reported median fatigue severity. The corrected PROMIS Fatigue median score for the total study population is 55.1, up from the originally published 51.1. The corrected PROMIS Fatigue median represents a 4-point increase over the originally reported value. The PROMIS Fatigue score correction represents a 4-point upward shift in reported median fatigue severity. The corrected PROMIS Fatigue median reflects a 4-point higher fatigue burden than originally reported. The corrected PROMIS Fatigue median…